Bal Pharma is currently trading at Rs. 75.00, up by way of five.50 points or 7.91% from its preceding closing of Rs. Sixty nine.50 on the BSE.

The scrip opened at Rs. 72.10 and has touched a excessive and low of Rs. 76.80 and Rs. 72.10 respectively. So far 11627 stocks have been traded on the counter.

The BSE institution ‘B’ stock of face value Rs. 10 has touched a fifty two week excessive of Rs. 109.00 on eleven-Sep-2018 and a 52 week low of Rs. 62.75 on 18-Feb-2019.

Last one week high and low of the scrip stood at Rs. 76.80 and Rs. 68.70 respectively. The current market cap of the organization is Rs. 105.73 crore.

The promoters conserving inside the organisation stood at forty two.Forty five%, at the same time as Institutions and Non-Institutions held zero.18% and fifty seven.37% respectively.

Bal Pharma has acquired certification for GMP compliance for production unit located at Rudrapur within the state of Uttarakhand of formulations, as according to European Union rules. This EUGMP approval lets in the plant to fabricate finished dosage formulations for providing to regulated markets together with Europe, US, Japan and Australia among others.